(A) Pharmacologic management service is a psychiatric/mental health/medical intervention used to reduce/stabilize and/or eliminate psychiatric symptoms with the goal of improved functioning, including management and reduction of symptoms. Pharmacologic management services should result in well-informed/educated individuals and family members and in decreased/minimized symptoms and improved/maintained functioning for individuals receiving the service. The purpose/intent is to:
(1) Address psychiatric/mental health needs as identified in the mental health assessment and documented in the client's ISP;
(2) Evaluate medication prescription, administration, monitoring, and supervision;
(3) Inform individuals and family regarding medication and its actions, effects and side effects so that they can effectively participate in decisions concerning medication that is administered/dispensed to them;
(4) Assist individuals in obtaining prescribed medications, when needed; and
(5) Provide follow-up, as needed.
(B) Pharmacologic management service shall consist of one or more of the following elements as they relate to the individual's psychiatric needs, and as clinically indicated:
(1) Performance of a psychiatric/mental health examination;
(2) Prescription of medications and related processes which include:
(a) Consideration of allergies, substance use, current medications, medical history, and physical status;
(b) Behavioral health education to individuals and/or families, (e.g., purpose, risks, side effects, and benefits of the medication prescribed); and
(c) Collaboration with the individual and/or family, including their response to the education, as clinically indicated. The method of delivery of education can be to an individual or group of individuals.
(3) Administration and supervision of medication and follow-up, as clinically indicated. Prescription, administration and supervision of medication is governed by professional licensure standards, Ohio Revised Code, Administrative Code, and scope of practice.
(a) Clinicians who order medications and persons who receive medication orders shall be appropriately licensed and acting within the scope of their practice.
(4) Medication monitoring consisting of monitoring the effects of medication, symptoms, behavioral health education and collaboration with the individual and/or family as clinically indicated. The method of delivery of medication monitoring can be to an individual or group of individuals.
(C) The following shall apply with regard to the use of interactive videoconferencing. Interactive videoconferencing is defined in Chapter 5122-24 of the Administrative Code.
(1) "Client site" means the location of a client at the time at which the service is furnished via interactive videoconferencing technology.
(2) "Provider site" means the site where the eligible practitioner furnishing the service is located at the time the service is rendered via interactive videoconferencing technology.
(3) The agency shall obtain from the client/parent/legal guardian, signed, written consent for the use of videoconferencing technology.
(4) It is the responsibility of the agency to assure contractually that any entity or individuals involved in the transmission of the information guarantee that the confidentiality of the information is protected. When the client chooses to utilize videoconferencing equipment at a client site that is not arranged for by the agency, e.g., at his/her home or that of a family or friend, the agency is not responsible for any breach of confidentiality caused by individuals present at the client site.
(5) The agency shall provide the client written information on how to access assistance in a crisis, including one caused by equipment malfunction or failure.
(6) It is the responsibility of the agency to assure that equipment meets standards sufficient to:
(a) Assure confidentiality of communication;
(b) Provide for interactive videoconferencing communication between the practitioner and the client; and
(c) Assure videoconferencing picture and audio are sufficient to assure real-time interaction between the client and the provider and to assure the quality of the service provided.
(d) The client site must also have a person available who is familiar with the operation of the videoconferencing equipment, in the event of a problem with the operation.
(e) If the client chooses to utilize videoconferencing equipment at a client site that is not arranged for by the agency, e.g., at his/her home or that of a family or friend, the agency is only responsible for assuring the equipment standards at the provider site.
(7) The decision of whether or not to provide initial or occasional in-person sessions shall be based upon client choice, appropriate clinical decision-making, and professional responsibility, including the requirements of professional licensing, registration or credentialing boards.
(D) Pharmacologic management service shall be provided and supervised by staff who are qualified according to rule 5122-29-30 of the Administrative Code.
R.C. 119.032 review dates: 04/14/2009 and 07/01/2014
Promulgated Under: 119.03
Statutory Authority: 5119.22 , 5119.61(A) , 5119.611(C)
Rule Amplifies: 5119.22 , 5119.61(A) , 5119.611(C)
Prior Effective Dates: 1-1-1991, 10-1-1993, 7- 15.2001, 3-25-2004, 12-15-2005, 12-13-2007